Tectonic Therapeutic, Inc. SEC filings TECX

Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
10-K Annual report Feb 26, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
10-K Annual report Mar 20, 2025 Dec 31, 2024
10-K Annual report Mar 14, 2024 Dec 31, 2023
ARS Annual report to shareholders May 5, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
10-K Annual report Mar 18, 2021 Dec 31, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Mar 25, 2019 Dec 31, 2018

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TECX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Watertown, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1681087
Former names
AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.